JPH04126524A - Diffusion dialysis - Google Patents

Diffusion dialysis

Info

Publication number
JPH04126524A
JPH04126524A JP24609290A JP24609290A JPH04126524A JP H04126524 A JPH04126524 A JP H04126524A JP 24609290 A JP24609290 A JP 24609290A JP 24609290 A JP24609290 A JP 24609290A JP H04126524 A JPH04126524 A JP H04126524A
Authority
JP
Japan
Prior art keywords
agent
diffusion dialysis
benzisothiazolin
antimold
mold
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP24609290A
Other languages
Japanese (ja)
Inventor
Ryosuke Aoki
良輔 青木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AGC Inc
Original Assignee
Asahi Glass Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Glass Co Ltd filed Critical Asahi Glass Co Ltd
Publication of JPH04126524A publication Critical patent/JPH04126524A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To effectively prevent generation of mold without cleaning the dialysis apparatus by disassembling, by incorporating an antimold agent comprising 1,2-benzisothiazolin-3-one into the liquid to be used for diffusion dialysis or to the recovery water. CONSTITUTION:An antimold agent comprising 1, 2-benzisothiazolin-3-one is incorporated into the liquid to be used for diffusion dialysis or into the recovery water. It is necessary to consider such problems for the antimold agent as the influence on the ion exchange membrane, residual amt. of the agent in the recovered acid, or influence of the agent itself on human body, etc. Therefore, the antimold agent is preferably used in the form of soln. or compounded mixture of ethylenediamine, dipropylene glycol, propyleneglycol, or triazine, and the antimold agent is incorporated by 0.1-100ppm. Thereby, generation of mold is effectively prevented without overhaul cleaning.

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は拡散透析法、特にカビの発生を防止した拡散透
析法に係るものである。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a diffusion dialysis method, particularly a diffusion dialysis method that prevents the growth of mold.

[従来の技術] 従来より、酸回収用として陰イオン交換膜を使用する拡
散透析法は広く実用化されている。
[Prior Art] Diffusion dialysis using an anion exchange membrane has been widely put into practical use for acid recovery.

この場合、特に硫酸を回収しようとする場合、陰イオン
交換膜の表面にカビが発生、繁殖する。これを防止する
為に、被拡散透析液及び/又は回収用水を予め紫外線殺
菌設備により殺菌したり、或は定期的にホルマリン溶液
を張り込む等の対策がとられている。
In this case, especially when attempting to recover sulfuric acid, mold grows and grows on the surface of the anion exchange membrane. In order to prevent this, measures are taken such as sterilizing the diffused dialysate and/or recovered water in advance using ultraviolet sterilization equipment, or periodically filling the dialysis fluid with formalin solution.

[発明が解決しようとする課題] しかしながら、紫外線殺菌は一過性であり、その後に侵
入するカビには何らの効果がなく、又ホルマリン溶液に
よる定期的な殺菌は、効果が比較的弱く、又臭気や排水
等問題が生じ、好ましい方法でない。
[Problems to be solved by the invention] However, ultraviolet sterilization is temporary and has no effect on mold that invades afterward, and periodic sterilization with formalin solution has a relatively weak effect, and This is not the preferred method as it causes problems such as odor and drainage.

か(して、カビにより汚染されたイオン交換膜は、解体
洗浄により除去しているのが現状である。この解体洗浄
には多大な労力と時間を要するのみならず、イオン交換
膜に人為的なダメージを与え、ひいてはイオン交換膜の
寿命を短くする致命的な欠点を有している。
Currently, ion exchange membranes contaminated with mold are removed by disassembly and cleaning.This disassembly and cleaning not only requires a great deal of labor and time, but also causes artificial damage to the ion exchange membrane. It has the fatal disadvantage of causing serious damage and shortening the life of the ion exchange membrane.

[課題を解決する為の手段] 本発明者は、このような点に鑑み、解体洗浄を行なうこ
とな(、有効にカビの発生を防止することを目的として
種々研究、検討した結果、被拡散透析液及び/又は回収
用水中に1.2−ベンズイソチアゾリン−3−オンを存
在させることにより前記目的を達成し得ることを見出し
、本発明はこれを要旨とするものである。
[Means for Solving the Problems] In view of the above, the inventor of the present invention has conducted various research and examinations with the aim of effectively preventing the growth of mold (without disassembling and cleaning it). It has been found that the above object can be achieved by the presence of 1,2-benzisothiazolin-3-one in the dialysate and/or the recovery water, and this is the gist of the present invention.

本発明において、防カビ剤はイオン交換膜への影響、回
収された酸中への残存の問題、防カビ剤自体の人体への
影響等が考慮されねばならない。この為、用いられる防
カビ剤はエチレンジアミン、ジプロピレングリコール、
プロピレングリコール、トリアジンの水溶液若しくは配
合混合物を用いるのが適当である。
In the present invention, the influence of the antifungal agent on the ion exchange membrane, the problem of remaining in the recovered acid, the influence of the antifungal agent itself on the human body, etc. must be taken into consideration. For this reason, the antifungal agents used are ethylenediamine, dipropylene glycol,
It is suitable to use aqueous solutions or blended mixtures of propylene glycol, triazine.

本発明に用いられる防カビ剤の使用量は、あまり多すぎ
ても回収液中に残存する量が多く、回収液の純度を損ね
、又あまり少なすぎても効果が不充分となり何れも好ま
しくない。この為、使用量は0.11−1O0pp、好
ましくは1〜10−ppm程度を採用するのが適当であ
る。実際の使用に当たっては、これら防カビ剤を回収用
水中に所定量加えるだけでよいが、拡散透析に際し、供
給される被透析液中にも防カビ剤や紫外線殺菌を行なう
ほうが好ましい。被透析液としては、例えば硫酸の回収
等酸の回収、アルカリの回収等に適宜使用できる。
If the amount of the antifungal agent used in the present invention is too large, a large amount will remain in the recovered liquid, impairing the purity of the recovered liquid, and if it is too small, the effect will be insufficient, both of which are undesirable. . For this reason, it is appropriate to adopt an amount of about 0.11-100 ppm, preferably about 1-10 ppm. In actual use, it is sufficient to simply add a predetermined amount of these antifungal agents to the water for recovery, but during diffusion dialysis, it is preferable to also apply an antifungal agent and ultraviolet sterilization to the dialysate fluid supplied. The fluid to be dialysed can be appropriately used for recovering acids such as sulfuric acid, recovering alkalis, and the like.

[実施例] 陰イオン交換膜100枚を組み込んだ旭硝子■製F−O
W型拡散透析槽を2基準備し、硫酸300g/12、硫
酸アルミニウム120g/βの原液からの硫酸回収を常
法に従って実施した。2基の使用回収用水はイオン交換
純水を使用し、予め千代田工販■製紫外線殺菌装置5H
−IDにより殺菌を行なった。
[Example] Asahi Glass F-O incorporating 100 anion exchange membranes
Two W-type diffusion dialysis tanks were prepared, and sulfuric acid recovery from a stock solution of 300 g/12 sulfuric acid and 120 g/β aluminum sulfate was performed according to a conventional method. The water for use and recovery in the two units uses ion-exchanged pure water, and is preheated using an ultraviolet sterilizer 5H manufactured by Chiyoda Kohan ■.
- Sterilization was performed by ID.

そして、一方の拡散透析槽の回収用水、及び被透析液中
には更に1.2−ベンズイソチアゾリン−3−オンのエ
チレンジアミン水溶液(有効成分濃度33%)を3 p
pm連続添加した。供給流量は同一条件とし、原液は5
.07β/時、回収用水は5.Oj2/時とした。当初
硫酸回収率は両者とも82%であったが、紫外線だけの
イオン交換水を使用したものは1ケ月後より次第に回収
率が低下し、4ケ月後には68%まで低下した。
Further, 3 p of an ethylenediamine aqueous solution of 1,2-benzisothiazolin-3-one (active ingredient concentration 33%) was added to the recovery water of one diffusion dialysis tank and the dialysate.
pm was added continuously. The supply flow rate is the same, and the stock solution is 5.
.. 07β/hour, water for recovery is 5. Oj2/hour. Initially, the sulfuric acid recovery rate was 82% in both cases, but in the case where ion-exchanged water with only ultraviolet rays was used, the recovery rate gradually decreased after one month and dropped to 68% after four months.

これに対し、1.2−ベンズイソチアゾリン−3−オン
を添加しているものは安定した硫酸回収率を維持し、4
ケ月後もその値は82%であった。この時点で解体点検
を行なったところ、紫外線だけの殺菌を行なっているイ
オン交換膜を使用しているものは、回収酸室の上部約%
に糸状のカビが多量に繁殖していた。1.2−ベンズイ
ソチアゾリン−3−オンを添加してものについては、何
ら異常は発見できなかった。
On the other hand, the one to which 1,2-benzisothiazolin-3-one was added maintained a stable sulfuric acid recovery rate and
After several months, the value remained at 82%. At this point, a disassembly and inspection was conducted, and it was found that approximately 30% of the upper part of the recovery acid chamber was using an ion-exchange membrane that sterilized only with ultraviolet light.
There was a large amount of filamentous mold growing. No abnormality was found in the sample to which 1,2-benzisothiazolin-3-one was added.

Claims (1)

【特許請求の範囲】 1、被拡散透析液及び/又は回収用水中に1,2−ベン
ズイソチアゾリン−3−オンからなる防カビ剤を存在さ
せることを特徴とする拡散透析法。 2、防カビ剤はエチレンジアミン、ジプロピレングリコ
ール、プロピレングリコール、トリアジンの水溶液若し
くは配合混合物である請求項1の拡散透析法。 3、防カビ剤は0.1〜100ppm存在させる請求項
1の拡散透析法。
[Scope of Claims] 1. A diffusion dialysis method characterized in that an antifungal agent consisting of 1,2-benzisothiazolin-3-one is present in the dialysate to be diffused and/or in the water for recovery. 2. The diffusion dialysis method according to claim 1, wherein the fungicide is an aqueous solution or a blended mixture of ethylenediamine, dipropylene glycol, propylene glycol, and triazine. 3. The diffusion dialysis method according to claim 1, wherein the antifungal agent is present in an amount of 0.1 to 100 ppm.
JP24609290A 1990-07-31 1990-09-18 Diffusion dialysis Pending JPH04126524A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2-201302 1990-07-31
JP20130290 1990-07-31

Publications (1)

Publication Number Publication Date
JPH04126524A true JPH04126524A (en) 1992-04-27

Family

ID=16438746

Family Applications (1)

Application Number Title Priority Date Filing Date
JP24609290A Pending JPH04126524A (en) 1990-07-31 1990-09-18 Diffusion dialysis

Country Status (1)

Country Link
JP (1) JPH04126524A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008272667A (en) * 2007-04-27 2008-11-13 Japan Organo Co Ltd Reverse osmosis membrane treatment agent and reverse osmosis membrane treatment method using it

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008272667A (en) * 2007-04-27 2008-11-13 Japan Organo Co Ltd Reverse osmosis membrane treatment agent and reverse osmosis membrane treatment method using it

Similar Documents

Publication Publication Date Title
JP2599204B2 (en) Hemodialysis agent
JP5685271B2 (en) Sterile composition containing peracetic acid without molybdate
AU593555B2 (en) Sterilant compositions
ATE242013T1 (en) DEVICE FOR WASHING AND DISINFECTING DIALYZERS USING ELECTROLYTICALLY PRODUCED ACID WATER
EP3233138B1 (en) Cleaning composition
JPS6022946B2 (en) Sterilization method for biological dialysis equipment
WO2009006493A3 (en) 'extended use dialysis system'
JPH09503417A (en) Dialyzer and reprocessing method
CA2000586C (en) Method of cleaning and/or disinfecting and sterilizing hemodyalisis apparatus
US5178830A (en) Method of cleaning, disinfecting and sterilizing hemodialysis apparatus
JP3053550B2 (en) How to clean medical equipment
JP2606910B2 (en) Ultrapure water production and supply equipment
JPH04126524A (en) Diffusion dialysis
CN108201628A (en) Including the method with process cycle in the post processing of acid concentrate combination type sterilizing and decalcification and preparation extracorporeal blood treat-ment apparatus
US6419850B1 (en) System and composition for decontaminating fluids
JP4332829B2 (en) Dialysis system
JP2694503B2 (en) Blood circulation in artificial dialysis, sterilization and purification method for dialysate piping pipeline
JPH04135559A (en) Disinfecting detergent for medical treating equipment for artificial dialysis or the like
JPH084787B2 (en) Liquid processing machine element
JPH03229416A (en) Method of sterilization washing of circulation route of pure water for washing in semiconductor manufacture
JPH05329340A (en) Membrane module
KR101279557B1 (en) Method for reusing dialyzer
JP2012187321A (en) Method for washing and disinfecting dialysate line in artificial dialyzer
JP3020709U (en) Aseptic. Water purifier for odorless water supply
JPH0630765B2 (en) Aseptic pure water supply method